Is Muscle Weakness a Common Side Effect of Skin Cancer Treatment?

Muscle weakness can happen with some skin cancer treatments, but it is not the most common side effect. It is seen most notably with modern immunotherapy drugs (checkpoint inhibitors like pembrolizumab, nivolumab, ipilimumab), where immune-related muscle inflammation (myositis) or nerve problems can occur and may range from mild aches to serious weakness needing urgent care. ^[1] These therapies can also cause joint and muscle pains (arthralgia/myalgia), which sometimes feel like weakness. ^[2] Traditional chemotherapy can contribute to fatigue, nerve injury, and functional decline, which may be experienced as weakness, though true inflammatory muscle damage is less typical compared with immunotherapy. ^[3] Topical skin cancer creams mainly cause local skin reactions and do not usually cause muscle weakness. ^[4]

---

Why It Happens

• Immunotherapy-related myositis and neuromuscular issues: Checkpoint inhibitors can trigger the immune system to attack muscles or nerves, leading to myositis, myasthenia-like symptoms, peripheral neuropathy, or other neurologic toxicities that present as weakness. ^[1] Clinicians monitor for arthralgia/myalgia with these drugs because symptoms can evolve and sometimes require steroids. ^[2]

• Chemotherapy and nerve/muscle effects: Several anti-cancer drugs can injure peripheral nerves, causing numbness, tingling, pain, and coordination problems that can be perceived as weakness and impair daily activities and balance. ^[5] Cancer care teams recognize that treatments may affect normal tissues including nerves and overall functional systems which can reduce strength and endurance. ^[3]

• Topical treatments: Prescription creams for non-melanoma skin cancers generally cause local skin irritation (redness, burning, crusting) and rarely systemic effects like muscle weakness. ^[4]

---

Warning Signs That Need Prompt Attention

• New or worsening muscle weakness (difficulty climbing stairs, lifting arms, standing from a chair). ^[2]
• Neck stiffness, droopy eyelids, double vision, trouble swallowing or breathing, or extreme fatigue, which can signal neuromuscular immune side effects. ^[1]
• Severe muscle pain with dark urine or marked weakness, which can suggest muscle breakdown. ^[2]

If these occur during immunotherapy, contacting your care team urgently is generally advised because early evaluation and treatment improve outcomes. ^[6]

---

How Clinicians Evaluate Muscle Weakness

• Blood tests: Markers of muscle inflammation and injury such as CK (creatine kinase) and aldolase, plus general inflammation labs (ESR, CRP). ^[7]
• Autoimmune/antibody panels: To look for immune-mediated muscle disease when suspected. ^[7]
• Additional labs: Depending on the situation, comprehensive metabolic panel, complete blood count, thyroid function and cortisol tests, since endocrine problems from immunotherapy can also cause fatigue and weakness. ^[6]
• Specialist referral: Rheumatology or neurology input is often sought when myositis or neuropathy is suspected. ^[2]

---

Management Strategies

Immunotherapy-Related Muscle Problems

• Severity-based approach: Mild aches may be managed with acetaminophen or NSAIDs if appropriate. ^[2] Moderate to severe symptoms often require corticosteroids (like prednisone) to calm the immune reaction; treatment may be held temporarily until stabilized. ^{[2] [6]}
• Escalation of care: If symptoms are serious (e.g., progressive weakness, breathing or swallowing problems), clinicians may withhold immunotherapy, give high-dose steroids, and involve specialists; additional immune-modulating therapies can be considered in refractory cases. ^{[6] [1]}

Chemotherapy-Induced Neuropathy or Functional Decline

• Dose adjustments: Reducing, delaying, or changing neurotoxic drugs can be considered to limit worsening nerve injury. ^[5]
• Symptom relief and safety: Pain management, fall-prevention strategies, and assistive devices help maintain independence. ^[3] Rehabilitation programs target strength, balance, and energy conservation to improve function. ^[8]

Rehabilitation and Exercise

• Cancer rehabilitation is beneficial: Structured physical therapy and occupational therapy can address weakness, balance issues, and daily activity challenges, often improving safety and quality of life. ^[3] Progressive exercise tailored to tolerance supports strength, endurance, and fatigue reduction during and after treatment. ^[9]

---

Practical Self-Care Tips

• Report symptoms early: New or worsening weakness, especially on immunotherapy, should be shared promptly so your team can order the right tests (CK, aldolase, ESR/CRP) and act quickly. ^{[7] [2]}
• Stay active within limits: Gentle, regular movement and needs-matched rehabilitation can help maintain strength and reduce fatigue; programs are often stepped and individualized. ^{[3] [10]}
• Medication safety: Discuss new medications or supplements with your oncology team to avoid interactions that can complicate side effects. ^[6]
• Protect nerves: If you’re on drugs known for neuropathy, monitor for tingling, numbness, or balance changes and ask about dose modifications or supportive measures. ^[5]

---

Summary

• Muscle weakness is possible but not the most common side effect of skin cancer treatment. It is most associated with immunotherapy, which can cause immune-related muscle and nerve problems requiring careful monitoring and often steroid treatment when moderate to severe. ^{[2] [1] [6]}
• Chemotherapy can produce neuropathy and functional decline that feel like weakness; management includes dose adjustments, symptom control, and rehabilitation. ^{[5] [3]}
• Topical creams mainly cause local skin reactions, not systemic muscle weakness. ^[4]
• Early recognition, appropriate tests (CK, aldolase, ESR/CRP), and a tailored plan with your care team are key to safe, effective management. ^{[7] [2] [6]}